Phase Ib study of RG7112 with doxorubicin (D) in advanced soft tissue sarcoma (ASTS).

被引：0
|
作者：
Chawla, Sant P.
Blay, Jean-Yves
Italiano, Antoine
Gutierrez, Martin
Le Cesne, Axel
Gomez-Roca, Carlos Alberto
Gouw, Launce G.
von Mehren, Margaret
Wagner, Andrew
Maki, Robert G.
Higgins, Brian
Middleton, Steven
Nichols, Gwen L.
Geho, David
Blotner, Steven
Zhi, Jianguo
Chen, Lin Chi
机构：
[1] Sarcoma Oncol Ctr, Santa Monica, CA USA
[2] Univ Lyon 1, Ctr Leon Berard, F-69365 Lyon, France
[3] Inst Bergonie, Bordeaux, France
[4] Hackensack Univ, Med Ctr, Hackensack, NJ USA
[5] Inst Gustave Roussy, Villejuif, France
[6] Inst Claudius Regaud, Toulouse, France
[7] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[8] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[9] Dana Farber Canc Inst, Boston, MA 02115 USA
[10] Mt Sinai Sch Med, New York, NY USA
[11] Hoffmann La Roche Inc, Translat Clin Res Ctr, Oncol Translat Med Grp, Nutley, NJ 07110 USA
[12] Hoffmann La Roche Inc, Translat Clin Res Ctr, Nutley, NJ 07110 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10514
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase lb study of ribociclib in combination with doxorubicin in advanced soft tissue sarcomas (aSTS).
    Davis, Lara E.
    Latour, Emile
    Burch, Reid
    Park, Byung
    Davis, Jessica L.
    Ryan, Christopher W.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Paclitaxel in combination with doxorubicin in advanced adult soft tissue sarcoma (ASTS): A Hellenic co-operative phase II study
    Bafaloukos, D
    Skarlos, D
    Fountzilas, G
    Dimopoulos, AM
    Kosmidis, P
    ANNALS OF ONCOLOGY, 1998, 9 : 119 - 119
  • [3] Phase IB/II trial of durvalumab plus doxorubicin combination in patients with advanced soft-tissue sarcoma
    Cho, Hee Jin
    Sim, Nam Suk
    Shin, Su-Jin
    Yun, Kum-Hee
    Lee, Young Han
    Jun, Hyun Jung
    Rha, Sun Young
    Kim, Hyo Song
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Standard-dose doxorubicin versus sequential dose-dense doxorubicin and ifosfamide in patients with untreated advanced soft tissue sarcoma (ASTS): A GEIS Study
    Maurel, J.
    Lopez-Pousa, A.
    de las Penas, R.
    Fra, J.
    Cruz, J.
    Martin, J.
    Casado, A.
    Martinez-Trufero, J.
    Poveda, A.
    Garcia del Muro, X.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] RG7112, a Small-Molecule Inhibitor of MDM2, Enhances Trabectedin Response in Soft Tissue Sarcomas
    Obrador-Hevia, Antonia
    Martinez-Font, Esther
    Felipe-Abrio, Irene
    Calabuig-Farinas, Silvia
    Serra-Sitjar, Margalida
    Antonio Lopez-Guerrero, Jose
    Ramos, Rafael
    Alemany, Regina
    Martin-Broto, Javier
    CANCER INVESTIGATION, 2015, 33 (09) : 440 - 450
  • [6] Phase Ib/II study of INNO-206 (EMCH-doxorubicin) in patients with soft tissue sarcoma
    Chawla, Sant P.
    Chua, Victoria S.
    Hendifar, Andrew
    Quon, Doris
    Nagre, Sandeep
    Ganjoo, Kristen N.
    Sankhala, Kamalesh
    Wieland, Scott
    Levitt, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Efficacy of trabectedin for advanced soft tissue sarcoma (ASTS): A retrospective single center analysis
    Martinez-Trufero, Javier
    Pajares, Isabel
    Hernandez Garcia, Alba
    Cebollero, Ana
    Calera, Lourdes
    Anton, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer
    Sessa, C.
    Perotti, A.
    Noberasco, C.
    De Braud, F.
    Gallerani, E.
    Cresta, S.
    Zucchetti, M.
    Vigano, L.
    Locatelli, A.
    Jimeno, J.
    Feilchenfeldt, J. W.
    D'Incalci, M.
    Capri, G.
    Ielmini, N.
    Gianni, L.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (07) : 1153 - 1161
  • [9] Phase 1 study of olaratumab plus doxorubicin in Japanese patients with advanced soft-tissue sarcoma
    Yonemori, Kan
    Kodaira, Makoto
    Satoh, Taroh
    Kudo, Toshihiro
    Takahashi, Shunji
    Nakano, Kenji
    Ando, Yuichi
    Shimokata, Tomoya
    Mori, Joji
    Inoue, Koichi
    Oakley, Gerard J.
    Sakaguchi, Sachi
    Tamura, Kenji
    CANCER SCIENCE, 2018, 109 (12) : 3962 - 3970
  • [10] Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma:: a study by the EORTC Soft Tissue and Bone Sarcoma Group
    Judson, I
    Radford, JA
    Harris, M
    Blay, JY
    van Hoesel, Q
    le Cesne, A
    van Oosterom, AT
    Clemons, MJ
    Kamby, C
    Hermans, C
    Whittaker, J
    di Paola, ED
    Verweij, J
    Nielsen, S
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (07) : 870 - 877
12345